Immunitybio Inc (NQ: IBRX )
6.450
+0.220
(+3.53%)
Streaming Delayed Price
Updated: 9:40 AM EDT, Jun 20, 2024
Add to My Watchlist
Press Releases about Immunitybio Inc![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Analysts see over 50% gains in these 2 mid-cap biotech stocks
February 14, 2024
Via MarketBeat
Topics
Artificial Intelligence
![]() ![]() ![]() From ImmunityBio, Inc.
Via Business Wire
![]() ![]() From ImmunityBio, Inc.
Via Business Wire
![]() ![]() ![]() ![]()
NASDAQ:IBRX Investor Notice: Deadline on August 29, 2023 in Lawsuit Against ImmunityBio, Inc.
August 28, 2023
Via SBWire
Topics
Lawsuit
![]() Via NewMediaWire
Topics
Lawsuit
![]() Via NewMediaWire
Topics
Lawsuit
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Penticton Herald
Phone number: 250-492-4002
E-mail: csr@ok.bc.ca
Address: 186 Nanaimo Ave. W.
Penticton, BC V2A 1N4
© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.